Advancements in utilizing CD34+ stem cells for repairing diabetic vascular damage
Open Access
- 28 January 2025
- journal article
- review article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 750, 151411
Abstract
No abstract availableKeywords
Funding Information
- Sichuan Provincial Science and Technology Support Program
- National Natural Science Foundation of China
This publication has 80 references indexed in Scilit:
- Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trialDiabetologia, 2023
- Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trialStem Cells Translational Medicine, 2020
- Quality-Quantity Control Culture Enhances Vasculogenesis and Wound Healing Efficacy of Human Diabetic Peripheral Blood CD34+ CellsStem Cells Translational Medicine, 2018
- Endothelial Progenitors: A Consensus Statement on NomenclatureStem Cells Translational Medicine, 2017
- Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in DiabetesStem Cells, 2016
- Ex Vivo Molecular Rejuvenation Improves the Therapeutic Activity of Senescent Human Cardiac Stem Cells in a Mouse Model of Myocardial InfarctionStem Cells, 2014
- A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complicationsDiabetologia, 2013
- Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickeningBasic Research in Cardiology, 2008
- Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetesDiabetologia, 2008
- Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in ratsDiabetologia, 2006